OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
Nicotinamide adenine dinucleotide. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: limited.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported (SC) | 50 mg | 1× daily | 0.5 mL | 50 u | 10 doses | |
| Standard (SC) | 100 mg | 1× daily | 1 mL | 100 u | 5 doses | |
| Upper reported range | 250–1000 mg over several hours | periodic | Set by body weight — can't be turned into a single amount to draw | |||
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 50 mg | daily | 0.5 mL | 50 u | 14 | 700 mg |
| Week 3 onward per 4 weeks from here on |
100 mg | daily | 1 mL | 100 u | 28 | 2800 mg |
A coenzyme rather than a peptide. Direct NAD+ administration is bioavailability-limited and often poorly tolerated (stinging, flushing, nausea). Most rigorous human research uses precursors — NR or NMN — rather than NAD+ itself.
Buy NAD+this peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
A senolytic peptide that disrupts the FOXO4–p53 interaction, selectively triggering apoptosis in senescent cells. The research dat…
A mitochondrial-derived peptide acting via AMPK on insulin sensitivity and metabolic homeostasis. Genuinely interesting mechanism …
Every compound compared in one table: dose range, how often, half-life and evidence tier.